A randomized, open-label, phase 2a study to assess the... : Hepatology
rm pharmacodynamics, pharmacokinetics, and safety of oral YAQ007 in patients with cirrhosis and a history of overt HE. Approach and Results: In this randomized, open-label, multicenter study, 48...
journals.lww.com